The rhesus macaque as an animal model for hemophilia B gene therapy

Blood

Volumn 93, Issue 6, 1999, Pages 1875-1881

  Lozier, Jay N ^a   Metzger, Mark E ^a   Donahue, Robert E ^a   Morgan, Richard A ^a,b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; GENE THERAPY; GENETIC POLYMORPHISM; HALF LIFE TIME; HEMOPHILIA B; IMMUNOGENICITY; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033559706     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.6.1875.406k16_1875_1881     Document Type: Article

References (40)

1. Lozier JN, Kessler CM: Clinical aspects and therapy of hemophilia, in Hoffman R, Benz E, Shattil S, Furie B, Cohen HJ (eds): Hematology, Principles and Practice, 3rd edition. New York, NY, Churchill-Livingstone, 1998
2. Nilsson IM, Berntorp E, Lofquist T, Pettersson H: Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 232:25, 1992
3. Petrini P, Lindvall N, Egberg N, Blomback M: Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Ped Hematol Oncol 13:280, 1991
4. St Louis D, Verma IM: An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 85:3150, 1988
5. Palmer TD, Thompson AR, Miller AD: Production of human factor IX in animals by genetically modified skin fibroblasts: Potential therapy for hemophilia B. Blood 73:438, 1989
6. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM, Woo SLC: In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262:117, 1993
7. Miyanohara A, Yee J-K, Bouic K, LaPorte P, Friedmann T: Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. Gene Ther 2:138, 1995
8. Chen L, Perlick H, Morgan RA: Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX. Hum Gene Ther 8:125, 1997
9. Wang J-M, Zheng H, Blaivas M, Kurachi K: Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: Feasibility of repeat application to obtain therapeutic levels. Blood 90:1075, 1997
10. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLC: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353, 1994
11. Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397, 1993
12. Walter J, You Q, Hagstrom JN, Sands M, High KA: Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc Natl Acad Sci USA 93:3056, 1996
13. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270, 1997
14. Herzog RW, Hagstrom JN, Kung S-H, Tai SJ, Wilson JM, Fisher KJ, High KA: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:5804, 1997
15. Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung S-H, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, Colosi P, Couto LB, High KA: Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600, 1998
16. Wang L, Zoppe M, Hackeng TM, Griffin JH, Lee K-F, Verma IM: A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 94:11563, 1997
17. Lin H-F, Maeda N, Smithies O, Straight DL, Stafford DW: A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90:3962, 1997
18. Evans JP, Brinkhous KM, Brayer GD, Reisner HM, High KA: Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci USA 86:10095, 1989
19. Mauser AE, Whitlark J, Whitney KM, Lothrop Jr. CD: A deletion mutation causes hemophilia B in Lhasa Apso dogs. Blood 88:3451, 1996
20. Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC: Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6:1039, 1995
21. Kay MA, Holterman A-I, Meuse L, Gown A, Ochs HD, Linsley PS, Wilson CB: Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet 11:191, 1995
22. Pang C-P, Crossley M, Kent G, Brownlee GG: Comparative sequence analysis of mammalian factor IX promoters. Nucleic Acids Res 18:6731, 1990
23. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K: Nucleotide sequence of the gene for human factor IX (Antihemophilic factor B). Biochemistry 24:3736, 1985
24. White II GC, Beebe A, Nielsen B: Recombinant factor IX. Thromb Haemost 78:261, 1997
25. Chou PY, Fasman GD: Prediction of protein conformation. Biochemistry 13:222, 1974
26. McGraw RA, Davis LM, Noyes CM, Lundblad RL, Roberts HR, Graham JB, Stafford DW: Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci USA 82:2847, 1985
27. Graham JB, Kunkel GR, Tennyson GS, Lord ST, Fowlkes DM: The Malmo polymorphism of factor IX: establishing the genotypes by rapid analysis of DNA. Blood 73:2104, 1989
28. Wu SM, Stafford DW, Frazier LD, Fu YY, High KA, Chu D, Sanchez-Vega B, Solera J: Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase. Blood 89:4058, 1997
29. Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, DiMichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Katz J, Bergmann F, Ljung R, Petrini P, Lusher JM: Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol 19:23, 1997
30. Ewenstein BM, Takemoto C, Warrier I, Lusher J, Saidi P, Eisele J, Ettinger LJ, Di Michele D: Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 89:1115, 1997
31. Ashwell G, Morell A: The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41:99, 1974
32. Rimon S, Melamed R, Savion N, Scott T, Nawroth PP, Stern DM: Identification of a factor IX/IXa binding protein on the endothelial cell surface. J Biol Chem 262:6023, 1987
33. Cheung WF, van den Born J, Kuhn K, Kjellen L, Hudson BG, Stafford DW: Identification of the endothelial cell binding site for factor IX. Proc Natl Acad Sci USA 93:11068, 1996
34. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991, 1994
35. Michou AI, Santoro L, Christ M, Julliard V, Pavirani A, Mahtali M: Adenovirus-mediated gene transfer: influence of transgene, mouse strain, and type of immune response on persistence of trangene expression. Gene Ther 4:473, 1997
36. Brinkhous KM, Sigman JL, Read MS, Stewart PF, McCarthy KP, Timony GA, Leppanen SD, Rup BJ, Keith Jr JC, Garzone PD, Schaub RG: Recombinant human factor IX: Replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood 88:2603, 1996
37. Nichols TC: Personal communication, August 21, 1998
38. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40, 1998
39. Herzog RW, Yang EY, Couto LB, Hagstrom NJ, Elwell D, Tai SJ, Colosi P, Podsakoff GM, Read MS, Bellinger DA, Brinkhous KM, Nichols T, Kurtzman GJ, High KA: AAV-niediated transfer in dogs with hemophilia B. American Society of Gene Therapy. Program and Abstracts, First Annual Meeting, May 28-31, 1998, page 116a
40. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injections of replication-defective adenovirus vectors. Nat Med 2:545, 1996